Home Factor company Leading healthcare supply provider in Saudi Arabia

Leading healthcare supply provider in Saudi Arabia


MADRID, Spain and WALL, NJ, Sept. 07, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions with Identity-Bound Biometrics (IBB), today announced that its business EMEA (Europe, Middle East and Africa) (formerly Swivel Secure Europe) has deployed AuthControl Sentry for one of Saudi Arabia’s leading healthcare supply providers in Riyadh, Saudi Arabia. The authentication solution will protect approximately 15,000 employee and vendor users with secure multi-factor access (MFA) with single sign-on (SSO) capabilities for all of its web and legacy applications. The client is the largest, value-driven, centralized sourcing, re-exporting, warehousing and distribution of pharmaceuticals, medical equipment and medical supplies company in the Kingdom of Saudi Arabia.

The goal of this project was to centralize all web and legal applications into a unified portal to provide employees and vendors across the Middle East with secure access to applications. Using the AuthControl Sentry solution will reduce password reset requests by removing the need for authentication for four or five different applications typically required to send a pharmaceutical or medical package through a courier.

“We are proud to help streamline the procurement process for one of the largest and most trusted suppliers to hospitals, clinics and pharmacies in Saudi Arabia and the Middle East. Secure and reliable authentication is essential for delivering urgent medication to patients in need. the time and friction in the authentication process can improve health service delivery and even save lives. For example, authentication for four popular software applications that previously took an average of four minutes has been reduced to just one minute with our AuthControl Sentry solution. saves time and increases the productivity and reliability of healthcare supply processes,” said Alex Rocha, Managing Director, BIO-key EMEA.

About BIO-key International, Inc. (www.bio-key.com)
BIO-key has over two decades of expertise in delivering authentication technologies for thousands of organizations and millions of users and is revolutionizing authentication with multi-factor Identity and Access Management (IAM) solutions focused on biometrics, including its PortalGuard IAM solution that provides security and secure access to high-value devices, information, applications and transactions. BIO-key’s patented software and hardware solutions with state-of-the-art biometric capabilities enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions and customized enterprise solutions. Swivel Secure Europe, SA, is a 100% owned BIO-key IAM solutions provider based in Madrid, Spain, serving the European, Middle Eastern and African markets.

BIO-key Safe Harbor Statement
All statements in this press release other than statements of historical fact are “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate”, “project”, “intend”, “expect”, “anticipate”, “believe” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are made based on the beliefs of management, as well as assumptions made by management and information currently available to it pursuant to the “safe harbor” provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included in or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, our limited loss and revenue history; our ability to raise additional capital; our ability to protect our intellectual property; changes in trading conditions; changes in our sales strategy and product development plans; market changes; the continued services of our senior management team; security failures; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, people and the geographic markets in which we operate; delays in product development and statements of assumptions underlying any of the above and other factors set forth under “Risk Factors” in our Annual Report on Form 10-K for fiscal year ended December 31, 2021 and others filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company assumes no obligation to disclose any revisions to these forward-looking statements. forward-looking statements, whether as a result of new information, future events or otherwise. In addition, there may be other factors not currently known to the Company that may affect the matters addressed in the forward-looking statements and may also cause actual results to differ. materially from those discussed, in particular the consequences of the coronavirus outbreak on economic conditions and the industry generally and the financial condition and operations The results of our Company, in particular, have been significant, are changing rapidly and do not can be predicted.

Engage with BIO-key:
Facebook – Company: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Company: https://www.linkedin.com/company/bio-key-international
Twitter – Company: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR

BIO-key media contact:
Erin Knapp
Communication of the subject
[email protected]

Investor contacts:
William Jones David Collins
IR catalyst
[email protected]